Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii.
Ali Dalir GhaffariAbdolhossein DalimiFatemeh GhaffarifarMajid PirestaniPublished in: Clinical and experimental vaccine research (2020)
This research provided important basic and conceptual data on GRA12 to develop an effective vaccine against acute and chronic toxoplasmosis for further in vivo investigations. More studies are required on vaccine development using the GRA12 alone or combined with other antigens in the future.